Drug Shortage Report for ACETYLCYSTEINE SOLUTION
Report ID | 196632 |
Drug Identification Number | 02243098 |
Brand name | ACETYLCYSTEINE SOLUTION |
Common or Proper name | ACETYLCYSTEINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ACETYLCYSTEINE |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL INTRAVENOUS INHALATION ORAL INTRAVENOUS INHALATION |
Packaging size | 30 ml 1LIVI |
ATC code | R05CB |
ATC description | EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-06-27 |
Estimated end date | 2023-07-07 |
Actual end date | 2023-07-10 |
Shortage status | Resolved |
Updated date | 2023-07-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-06-27 | English | Compare |
v2 | 2023-06-27 | English | Compare |
v3 | 2023-06-27 | French | Compare |
v4 | 2023-06-28 | English | Compare |
v5 | 2023-07-10 | English | Compare |
v6 | 2023-07-10 | French | Compare |
v7 | 2023-07-11 | English | Compare |
Showing 1 to 7 of 7